STAAR Surgical PE Ratio 2010-2023 | STAA

Current and historical p/e ratio for STAAR Surgical (STAA) from 2010 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. STAAR Surgical PE ratio as of April 22, 2024 is 71.61.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

STAAR Surgical PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-04-23 48.19 112.07
2023-12-31 31.21 $0.43 72.58
2023-09-30 40.18 $0.39 103.03
2023-06-30 52.57 $0.50 105.14
2023-03-31 63.95 $0.64 99.92
2022-12-31 48.54 $0.78 62.23
2022-09-30 70.55 $0.76 92.83
2022-06-30 70.93 $0.67 105.87
2022-03-31 79.91 $0.58 137.78
2021-12-31 91.30 $0.49 186.33
2021-09-30 128.53 $0.46 279.41
2021-06-30 152.50 $0.42 363.10
2021-03-31 105.41 $0.22 479.14
2020-12-31 79.22 $0.12 660.17
2020-09-30 56.56 $0.19 297.68
2020-06-30 61.54 $0.16 384.63
2020-03-31 32.26 $0.27 119.48
2019-12-31 35.17 $0.30 117.23
2019-09-30 25.78 $0.18 143.22
2019-06-30 29.38 $0.16 183.63
2019-03-31 34.19 $0.12 284.92
2018-12-31 31.91 $0.10 319.10
2018-09-30 48.00 $0.08 600.00
2018-06-30 31.00 $0.08 387.50
2018-03-31 14.80 $0.02 740.00
2017-12-31 15.50 $-0.04 0.00
2017-09-30 12.45 $-0.04 0.00
2017-06-30 10.80 $-0.11 0.00
2017-03-31 9.80 $-0.14 0.00
2016-12-31 10.85 $-0.29 0.00
2016-09-30 9.40 $-0.31 0.00
2016-06-30 5.51 $-0.31 0.00
2016-03-31 7.39 $-0.30 0.00
2015-12-31 7.14 $-0.16 0.00
2015-09-30 7.76 $-0.21 0.00
2015-06-30 9.66 $-0.24 0.00
2015-03-31 7.43 $-0.25 0.00
2014-12-31 9.11 $-0.23 0.00
2014-09-30 10.63 $-0.18 0.00
2014-06-30 16.80 $-0.10 0.00
2014-03-31 18.80 $-0.04 0.00
2013-12-31 16.19 $0.01 0.00
2013-09-30 13.54 $-0.01 0.00
2013-06-30 10.15 $-0.02 0.00
2013-03-31 5.63 $-0.04 0.00
2012-12-31 6.10 $-0.04 0.00
2012-09-30 7.56 0 0.00
2012-06-30 7.77 0 0.00
2012-03-31 10.83 $0.03 361.00
2011-12-31 10.49 $0.03 349.67
2011-09-30 7.80 $0.01 780.00
2011-06-30 5.30 $-0.02 0.00
2011-03-31 5.57 $-0.09 0.00
2010-12-31 6.10 $0.00 0.00
2010-09-30 5.41 $-0.25 0.00
2010-06-30 5.72 $-0.28 0.00
2010-03-31 3.82 $-0.27 0.00
2009-12-31 3.10 $-0.43 0.00
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $2.275B $0.322B
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $69.294B 18.55
Becton Dickinson (BDX) United States $67.568B 19.62
West Pharmaceutical Services (WST) United States $27.478B 46.45
Cardinal Health (CAH) United States $25.012B 15.03
Align Technology (ALGN) United States $22.637B 45.65
Cooper (COO) United States $17.896B 27.08
Labcorp (LH) United States $17.083B 14.59
Henry Schein (HSIC) United States $9.256B 16.01
DENTSPLY SIRONA (XRAY) United States $6.298B 16.60
Merit Medical Systems (MMSI) United States $4.253B 24.34
Patterson (PDCO) United States $2.321B 11.12
CONMED (CNMD) United States $2.236B 21.05
Atrion (ATRI) United States $0.704B 36.25
Lifevantage (LFVN) United States $0.078B 12.60
Pro-Dex (PDEX) United States $0.065B 24.72
Biolase (BIOL) United States $0.005B 0.00